Fortis Malar Hospitals Reports FY26 Standalone Net Profit of Rs 420.26 Lakhs
Fortis Malar Hospitals Limited published audited standalone and consolidated financial results for FY26, with standalone net profit after tax rising to Rs 420.26 lakhs from Rs 41.00 lakhs in FY25, and consolidated net profit reaching Rs 413.74 lakhs from Rs 39.20 lakhs. Standalone total revenue from operations grew to Rs 630.18 lakhs from Rs 271.72 lakhs, while consolidated revenue rose to Rs 635.29 lakhs. The statutory auditors issued an unmodified opinion but included an Emphasis of Matter noting the cessation of business operations following a slump sale, with management citing cash and cash equivalents of approximately Rs 3,458.24 lakhs as sufficient to meet obligations.
*this image is generated using AI for illustrative purposes only.
Fortis Malar Hospitals Limited published its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, via newspaper advertisements in the English daily Business Standard (all editions) and Punjabi daily Rozana Spokesman (Mohali edition) on May 19, 2026. The Board of Directors had convened on May 18, 2026, to approve the results, and also adopted modifications to the policy for determining materiality of events and updated the Code of Conduct for the prevention of Insider Trading.
Standalone Financial Performance
On a standalone basis, Fortis Malar Hospitals recorded a net profit after tax of Rs 420.26 lakhs for the financial year ended March 31, 2026, compared to Rs 41.00 lakhs in the previous financial year — reflecting a significant year-on-year improvement. Total revenue from operations for the full year stood at Rs 630.18 lakhs, up from Rs 271.72 lakhs in the prior year. For the quarter ended March 31, 2026, the standalone net profit after tax was a loss of Rs 2.98 lakhs, compared to a profit of Rs 36.17 lakhs in the corresponding quarter of the previous year.
| Particulars | Q4 FY26 (Audited) | Q3 FY26 (Un-Audited) | Q4 FY25 (Audited) | FY26 (Audited) | FY25 (Audited) |
|---|---|---|---|---|---|
| Total Revenue from Operations (₹ in Lakhs) | 65.63 | 52.11 | 76.73 | 630.18 | 271.72 |
| Net Profit/(Loss) before Tax (₹ in Lakhs) | 12.22 | 21.01 | 39.76 | 479.12 | 58.59 |
| Net Profit/(Loss) after Tax (₹ in Lakhs) | (2.98) | 3.59 | 36.17 | 420.26 | 41.00 |
| Total Comprehensive Income (₹ in Lakhs) | (2.98) | 3.59 | 36.17 | 420.26 | 41.00 |
| Basic EPS (₹) | (0.02) | 0.02 | 0.19 | 2.24 | 0.22 |
| Diluted EPS (₹) | (0.02) | 0.02 | 0.19 | 2.24 | 0.22 |
The paid-up equity share capital remained unchanged at Rs 1,875.70 lakhs (face value of Rs 10 per share). Reserves (excluding revaluation reserve) as shown in the audited balance sheet stood at Rs 1,540.97 lakhs for FY26, compared to Rs 1,120.71 lakhs for FY25.
Consolidated Financial Performance
On a consolidated basis, the company reported a net profit after tax of Rs 413.74 lakhs for FY26, against Rs 39.20 lakhs in the previous year. Consolidated total revenue from operations for the full year was Rs 635.29 lakhs, compared to Rs 271.72 lakhs in the prior year. For the quarter ended March 31, 2026, the consolidated net profit after tax was a loss of Rs 4.50 lakhs, against a profit of Rs 36.05 lakhs in the same quarter of the previous year.
| Particulars | Q4 FY26 (Audited) | Q3 FY26 (Un-Audited) | Q4 FY25 (Audited) | FY26 (Audited) | FY25 (Audited) |
|---|---|---|---|---|---|
| Total Revenue from Operations (₹ in Lakhs) | 65.94 | 52.36 | 76.73 | 635.29 | 271.72 |
| Net Profit/(Loss) before Tax (₹ in Lakhs) | 10.70 | 18.96 | 39.66 | 472.60 | 56.81 |
| Net Profit/(Loss) after Tax (₹ in Lakhs) | (4.50) | 1.54 | 36.05 | 413.74 | 39.20 |
| Total Comprehensive Income (₹ in Lakhs) | (4.50) | 1.54 | 36.05 | 413.74 | 39.20 |
| Basic EPS (₹) | (0.02) | 0.01 | 0.19 | 2.21 | 0.21 |
| Diluted EPS (₹) | (0.02) | 0.01 | 0.19 | 2.21 | 0.21 |
Consolidated paid-up equity share capital also remained at Rs 1,875.70 lakhs. Reserves (excluding revaluation reserve) as at March 31, 2025 stood at Rs 1,558.95 lakhs for FY26, compared to Rs 1,145.21 lakhs for FY25.
Auditor's Report and Going Concern
M/s B S R & Co. LLP, the Statutory Auditors, issued an unmodified opinion on the standalone and consolidated financial statements. However, the auditors included an 'Emphasis of Matter' noting that the company ceased to have any business operations following a slump sale transaction. Despite the lack of visibility for new operations, the management believes current cash and cash equivalents of approximately Rs 3,458.24 lakhs are sufficient to settle obligations and meet financial requirements. Consequently, the results have been prepared on a going concern basis.
Trading Window Closure
In accordance with regulatory requirements, the trading window for dealing in the company's securities remains closed until 48 hours after the announcement of the financial results, extending up to May 20, 2026. The full format of the standalone and consolidated results is available on the BSE website at www.bseindia.com and on the company's website at www.fortismalarhospital.com .
Historical Stock Returns for Fortis Malar Hospitals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.36% | +0.50% | -7.07% | -15.22% | -29.50% | -19.85% |
What are Fortis Malar Hospitals' plans for deploying its Rs 3,458 lakhs cash reserves following the slump sale, and are there any potential acquisition or re-entry targets in the healthcare sector?
How long can Fortis Malar Hospitals sustain its going concern status solely on cash reserves without active business operations, and what triggers could force a change in this assessment?
Will the parent company Fortis Healthcare consider merging or delisting Fortis Malar Hospitals given its cessation of operations and the administrative costs of maintaining a listed entity?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
